SUBSCRIBE
SUBSCRIBE
News   Business

Daiichi Sankyo Co Ltd. Posts $3.7 Billion Q3 Loss on Ranbaxy Pharmaceuticals Inc.

January 30, 2009 | 
1 min read
TOKYO, Jan 30 (Reuters) - Daiichi Sankyo, Japan's third-largest drugmaker, posted a $3.7 billion quarterly loss and forecast its first annual loss, hit by a slide in the value of its stake in India's Ranbaxy Laboratories.
Earnings Asia
Daiichi Sankyo
MORE ON THIS TOPIC
Contemporary art collage of hand holding an arrow showing fall. Modern design. Copy space.
Earnings
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Contemporary art collage. Hand put money to golden stack of coins, meaning income from investment. Concept of business strategy, investment, development, market, finance.
Earnings
Lilly’s Revenue Leaps 45% Thanks to Zepbound, Mounjaro, Of Course
May 1, 2025
 · 
1 min read
 · 
Annalee Armstrong
Paying double wages or giving double money, greed and lust, double work for double wages, one person splitting into two and claiming both
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
 · 
5 min read
 · 
Annalee Armstrong
command failed. Business team walk in a line following faulty orders vector
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
April 30, 2025
 · 
1 min read
 · 
Angela Gabriel